Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2022-08-22 | 2022-07-02 |
| Drug Identification Number | 02139510 | 02139510 |
| Brand name | SODIUM CHLORIDE INJECTION, USP | SODIUM CHLORIDE INJECTION, USP |
| Common or Proper name | SODIUM CHLORIDE INJECTION, USP | SODIUM CHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | SODIUM CHLORIDE | SODIUM CHLORIDE |
| Strength(s) | 234MG | 234MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 30 ML | 30 ML |
| ATC code | B05XA | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-07-01 | 2022-07-01 |
| Actual start date | 2022-07-01 | 2022-07-01 |
| Estimated end date | 2022-08-15 | 2022-07-31 |
| Actual end date | 2022-08-15 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | We will be extending our backorder on Sodium Chloride Injection, USP 4 mEq/mL SD Vial 30 mL until August 15, 2022. Once available, this product will be placed on allocation. Contract customers will be allocated 100% of historical monthly demand. | Fresenius Kabi Canada regrets to advise that due to a production delay, we will be encountering a supply interruption on our Sodium Chloride Injection, USP 4 mEq/mL SD Vial 30 mL ef fective July 1, 2022 until July 31, 2022. Our Sodium Chloride Injection, USP 4mEq/mL Maxivial® 100 mL will be available for substitution. Allocations for our 100 mL will be increased to cover 100% of historical 100 mL monthly demand plus 100% of 30 mL demand at a 1:3 ratio (1 vial of 100 mL = 3 vials of 30 mL). |
| Health Canada comments |